Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Plos One|March 4, 2017
Viruses in case series of tumors: Consistent presence in different cancers in the same subjectLaila Sara Arroyo Mühr, Maria Hortlund, Zurab Bzhalava, et al.
Virology|May 18, 2018
Viremia preceding multiple sclerosis: Two nested case-control studiesEmilie Hultin, Laila Sara Arroyo Mühr, Zurab Bzhalava, et al.
Plos Medicine|August 23, 2021
Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trialK Miriam Elfström, Carina Eklund, Helena Lamin, et al.
BMJ Open|June 2, 2017
Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60Helena Lamin, Carina Eklund, Klara Miriam Elfström, et al.
Vaccine|May 21, 2018
Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programsJoakim Dillner, Mari Nygård, Christian Munk, et al.
International Journal of Cancer|August 26, 2017
Viruses in cancers among the immunosuppressedLaila Sara Arroyo Mühr, Zurab Bzhalava, Maria Hortlund, et al.
Clinical and Vaccine Immunology : CVI|June 19, 2015
Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV VaccineMari Nygård, Alfred Saah, Christian Munk, et al.
Contemporary Clinical Trials|April 5, 2020
Use of real-world data for HPV vaccine trial follow-up in the Nordic regionEspen Enerly, Sophie Berger, Susanne K Kjær, et al.
Plos One|February 8, 2014
Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillanceMari Nygård, Bo Terning Hansen, Joakim Dillner, et al.
Human Vaccines & Immunotherapeutics|September 29, 2020
Human papillomavirus genotype-specific risks for cervical intraepithelial lesionsMari Nygård, Bo T Hansen, Susanne K Kjaer, et al.
Pageof 3